T1	Participants 52 119	type 2 diabetic patients with late failure of sulphonylurea therapy
T2	Participants 229 349	patients with type 2 diabetes receiving exogenous insulin due to secondary failure of maximum dose sulphonylurea therapy
T3	Participants 444 583	48 type 2 diabetic patients with late-term failure following at least 3 years of sulphonylurea therapy requiring additional insulin therapy
